Literature DB >> 18936377

Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.

Lorenzo Capussotti1, Andrea Muratore, Filippo Baracchi, Bernard Lelong, Alessandro Ferrero, Daniele Regge, Jean Robert Delpero.   

Abstract

OBJECTIVE: To compare the volumetric increase of segments 2 and 3, segment 4, and the caudate lobe after portal vein ligation (PVL) and portal vein embolization (PVE). The small size of the remnant liver and chemotherapy-induced liver injury increase the risk of postoperative hepatic insufficiency after major hepatic resection for colorectal liver metastases. Portal vein ligation has been suggested to be less effective than embolization in inducing hypertrophy of the remnant liver. DESIGN, SETTING, AND PATIENTS: We retrospectively reviewed 48 patients with colorectal liver metastases who underwent PVL (n = 17) or PVE (n = 31) at the Istituto per la Ricerca e la Cura del Cancro or the Institut Paoli-Calmette from March 1, 2000, through August 31, 2006. MAIN OUTCOME MEASURES: To compare the volume increase of segments 2 and 3, segment 4, and of the caudate lobe in patients who have undergone PVL or PVE in preparation for a major hepatic resection.
RESULTS: There were no deaths related to PVE or PVL. Portal vein ligation was associated with resection of synchronous colorectal cancer in 16 patients. Resection of a liver metastasis in the remnant liver was performed in 11 patients. The median estimated baseline volume of segments 2 and 3 was 17.7% in the PVL group and 17.5% in the PVE group (P = .72). After PVL or PVE, it increased to 26.9% and 24.7%, respectively (P = .95), for volumetric increases of 43.1% and 53.4%, respectively (P = .39). The volumetric increases of segment 4 and the caudate lobe were similar.
CONCLUSION: Portal vein ligation is as effective as PVE in inducing hypertrophy of the remnant liver volume.

Entities:  

Mesh:

Year:  2008        PMID: 18936377     DOI: 10.1001/archsurg.143.10.978

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  48 in total

1.  Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation.

Authors:  Hiroya Iida; Tsukasa Aihara; Shinichi Ikuta; Hidenori Yoshie; Naoki Yamanaka
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

2.  Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.

Authors:  Sebastian Senger; Jens Sperling; Barbara Oberkircher; Martin K Schilling; Otto Kollmar; Michael D Menger; Christian Ziemann
Journal:  Clin Exp Metastasis       Date:  2017-06-19       Impact factor: 5.150

Review 3.  Liver function impairment in liver transplantation and after extended hepatectomy.

Authors:  Matteo Serenari; Matteo Cescon; Alessandro Cucchetti; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 4.  Current position of ALPPS in the surgical landscape of CRLM treatment proposals.

Authors:  Marcello Donati; Gregor A Stavrou; Karl J Oldhafer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

Review 5.  Post-hepatectomy liver failure in patients with colorectal liver metastases.

Authors:  Masato Narita; Elie Oussoultzoglou; Philippe Bachellier; Daniel Jaeck; Shinji Uemoto
Journal:  Surg Today       Date:  2015-01-29       Impact factor: 2.549

Review 6.  Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.

Authors:  Kristina Hasselgren; Per Sandström; Bergthor Björnsson
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

7.  Liver kinetic growth rate predicts postoperative liver failure after ALPPS.

Authors:  Patryk Kambakamba; Daniel Stocker; Cäcilia S Reiner; Thi Dan Nguyen-Kim; Michael Linecker; Dilmurodjon Eshmuminov; Henrik Petrowsky; Pierre-Alain Clavien; Mickael Lesurtel
Journal:  HPB (Oxford)       Date:  2016-08-11       Impact factor: 3.647

8.  Our initial experience with ALPPS technique: encouraging results.

Authors:  Sofía Sala; Victoria Ardiles; Marina Ulla; Fernando Alvarez; Juan Pekolj; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2012-08-18

9.  Is there new hope for patients with marginally resectable liver malignancies.

Authors:  Martin Loos; Helmut Friess
Journal:  World J Gastrointest Surg       Date:  2012-07-27

Review 10.  Quality improvement for portal vein embolization.

Authors:  Alban Denys; Pierre Bize; Nicolas Demartines; Frederic Deschamps; Thierry De Baere
Journal:  Cardiovasc Intervent Radiol       Date:  2010-02-04       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.